MedPath

Hubei Feilihua Quartz Glass Co.Ltd

Ownership
-
Established
1999-01-22
Employees
1.4K
Market Cap
-
Website
www.feilihua.com
Introduction

The company's predecessor was founded in 1966 and listed on GEM on September 10, 2014. It now has six production bases in Jingzhou, Qianjiang, Shanghai, Hefei, Taizhou, and Jinan, as well as three R&D platforms: Jingzhou Technology Center, Shanghai R&D Branch, and Wuhan Institute of Technology. It has now become an integrated processing enterprise for quartz glass materials and products with great influence and scale advantages at home and abroad, an integrated manufacturer of quartz fiber materials, fabrics and composites. It is the first quartz material supplier in China to pass integrated circuit chip admission certification, the first quartz processor among local companies to obtain certification from major domestic semiconductor equipment manufacturers, and one of the few enterprises in the world with the ability to mass produce quartz fibers. The company is mainly engaged in technology development, technology transfer, technical consulting and technical services for new material products and equipment; manufacturing and sales of quartz glass materials, quartz glass products, quartz glass fiber materials, composite materials and products. The company's main products include quartz glass ingots, tubes, rods, plates, sheets, quartz glass devices, quartz glass fiber series products, quartz glass fiber three-dimensional woven prefabricated parts, and composites based on quartz glass fiber. Corporate honors: National Corporate Culture Construction Gold Award, National Enterprise and Enterprise Intellectual Property Pilot Unit, Jingzhou Jingjiang Quality Award. In 2019, the company won honorary titles such as the “13th China Listed Company Value Selection”, “Top 10 GEM Listed Companies”, “Light of Quality” quality benchmark enterprise, and an invisible champion model enterprise in the pillar industry segment of Hubei Province.

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Oxygen Supplies for Medicine

Product Name
医用氧(气态)
Approval Number
国药准字H42022936
Approval Date
Sep 30, 2010
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.